TCL Archive Cancer Policy: Reports Lists 10 Recommendations TO Improve Quality of Care, Measurement April 9, 1999
TCL Archive NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System August 26, 1977
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983